Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Senataxin (SETX) protein (Myc-DYKDDDDK Tag)

SETX Spezies: Human Wirt: HEK-293T Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
Produktnummer ABIN2731631
  • Target Alle Senataxin (SETX) Produkte
    Senataxin (SETX)
    Protein-Typ
    Recombinant
    Spezies
    Human
    Quelle
    HEK-293T Cells
    Aufreinigungstag / Konjugat
    Myc-DYKDDDDK Tag
    Applikation
    Antibody Production (AbP), Standard (STD)
    Produktmerkmale
    • Recombinant human Senataxin (SETX) protein expressed in HEK293 cell.
    • Produced with end-sequenced ORF clone
    Reinheit
    > 80 % as determined by SDS-PAGE and Coomassie blue staining
  • Applikationshinweise
    Recombinant human proteins can be used for:
    Native antigens for optimized antibody production
    Positive controls in ELISA and other antibody assays
    Kommentare

    The tag is located at the C-terminal.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    50 μg/mL
    Buffer
    25 mM Tris-HCl, pH 7.3, 100 mM glycine, and 10 % glycerol.
    Lagerung
    -80 °C
    Informationen zur Lagerung
    Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
  • Target
    Senataxin (SETX)
    Abstract
    SETX Produkte
    Hintergrund
    This gene encodes a protein named for its homology to the Sen1p protein of fungi which has RNA helicase activity encoded by a domain at the C-terminal end of the protein. The protein encoded by this gene contains a DNA/RNA helicase domain at its C-terminal end which suggests that it may be involved in both DNA and RNA processing. Mutations in this gene have been associated with ataxia-ocular apraxia-2 (AOA2) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis (ALS4).
    Molekulargewicht
    57.8 kDa
    NCBI Accession
    NP_055861
Sie sind hier:
Kundenservice